At the Department of Toxicogenomics (TGX), a multidisciplinary team of (cell) biologists, chemists, geneticists, toxicologists and bioinformaticians is working in close collaboration to establish the biological impact of exposures to potentially toxic compounds and to develop safe therapeutic strategies for genetic and non-genetic diseases. The rapid development of omics-technologies, has enabled us to establish responses on different molecular levels with higher sensitivity than most classical effect markers, and providing information on the involved molecular mechanisms of action. As such, toxicogenomics research combines toxicology with genomics approaches, and in particular next generation sequencing, in order to obtain more accurate understanding of toxicological processes and related disease mechanisms in order to maintain, restore or improve normal function. The application of these innovative omics-technologies in in vitro investigations of human, (patient-derived) cell models, in human population studies and in human health risk analysis can be regarded as the central research paradigm of our department.
- Focuses on more accurate understanding of toxicological processes
- Led by prof. dr. T. de Kok
TGX applies innovative -omics technologies, cellular models, and bioinformatics tools to characterize, prevent and treat complex human diseases and improve environmental safety.
TGX is leading in international networks that develop and apply innovative -omics technologies, cellular models, and bioinformatics tools to unravel the toxicological and molecular basis of cancer, neurodegenerative, mitochondrial, and muscular diseases. TGX works on (personalized) prevention and treatment strategies, using nutrition, supplements, drugs, gene correction, and stem cell approaches to improve human health and environmental safety and reduce animal experiments.
The department has strong collaborations both on the national level, and on the international level in the context of numerous EU and non-EU projects. Within Maastricht University there is a long history of collaboration with various clinical departments in the Maastricht University Medical Centre (MUMC+). The Department of Toxicogenomics is part of the GROW School for Oncology and Reproduction and the MHeNs School for Mental Health and Neuroscience and involved in the Maastricht Centre for Systems Biology (MaCSBio).
Maastricht University takes pride in the impressive initiatives that elevate the quality of our education. Therefore, we annually present the Wynand Wijnen Education Prize in honour of the staff members who make these initiatives possible and thereby contribute significantly to education.
During the 52nd EUROTOX congress in Sevilla (Spain), three of the four encouragement prizes went to FHML PhD students/PostDocs (Department Toxicogenomics). They won the award for their poster. Circa 800 posters were presented during the congress.